2006
DOI: 10.1272/jnms.73.89
|View full text |Cite
|
Sign up to set email alerts
|

The Treatment of Refractory Pneumothorax in Diffuse Panbronchiolitis by Intravenous Administration of Coagulation Factor XIII Concentrate

Abstract: This case report presents a patient with advanced diffuse panbronchiolitis accompanied by chronic respiratory failure, marked cachexia, and refractory spontaneous pneumothorax.Because instillation of a pleurodesis agent and thoracoscopy were considered highly risky and invasive, we instead treated the patient with intravenous administration of a coagulation factor XIII concentrate, and the pneumothorax resolved. This case suggests refractory pneumothorax in a restrictive ventilatory disorder can be effectively… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2008
2008
2022
2022

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 12 publications
0
2
0
Order By: Relevance
“…Additionally, plasma factor XIII has been reported to be a fistula-healing factor and intraoperative bleeding (29,30,45,46). In lung disease, there are some reports related to therapeutic effect of pneumothorax and prolonged air leak after pulmonary lobectomy (47,48). However, effect of plasma factor XIII is controversial (49).…”
Section: Discussionmentioning
confidence: 99%
“…Additionally, plasma factor XIII has been reported to be a fistula-healing factor and intraoperative bleeding (29,30,45,46). In lung disease, there are some reports related to therapeutic effect of pneumothorax and prolonged air leak after pulmonary lobectomy (47,48). However, effect of plasma factor XIII is controversial (49).…”
Section: Discussionmentioning
confidence: 99%
“…If air leakage persists for more than 2 days, we should start to check whether the patient can tolerate an operation under general anesthesia and consult with the thoracic surgeon and anesthesiologist. When the patient cannot endure an operation, other treatments such as pleurodesis, endoscopic bronchial occlusion, and intravenous coagulation factor XIII concentrate therapy should be considered (9,10).…”
Section: Decision To Perform Surgerymentioning
confidence: 99%